Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Caffeine can potentially treat common hair loss by counteracting hair follicle shrinkage caused by hormones.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Minoxidil can reduce functions related to androgen receptors.

The LncRNA AC010789.1 slows down hair loss by promoting hair follicle growth and interacting with miR-21 and the Wnt/β-catenin pathway.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Finasteride effectively treats hidradenitis suppurativa for most patients.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Finasteride effectively treats male hair loss, improving growth and density.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Finasteride 2.5 mg/day can effectively treat female hair loss.

Trichoscopy shows hair diameter variability, vellus hairs, and the peripilar sign are key indicators for diagnosing Androgenetic Alopecia.

More personalized and effective treatments for androgenetic alopecia are needed.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Finasteride effectively treats male hair loss, increasing length and thickness.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.